PMGC Holdings Inc. ELAB
Set alert
2.60 USD -0.04 -1.52%
At close · Oct 30
2.70 +0.10 +3.85%
After hours · Oct 30, 4:31 PM ET
2.51 Day range 2.70
2.57 52-week range 1,447.20
- YTD
- -99.27%
- 1 year
- -99.82%
- Open
- 2.54
- Prev close
- 2.64
- Mkt cap
- 2.10M
- Vol
- 7.49K
- Avg vol
- 42.34K
- EPS
- -1,748.36
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.51
- High
- 2.70
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.17
- Inst. own
- 18.20%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 7.79
- 200-d avg
- 77.01
- 1y target
- 0.00
2Y chart
Events in this range
- Nov 27, 2024Split: 1 for 200
- Mar 10, 2025Split: 1 for 7
- Sep 2, 2025Split: 1 for 3.5
- Jan 6, 2026Split: 1 for 4
- Mar 10, 2026Split: 1 for 6
- Aug 21, 2026Split: 1 for 10
Signals (57)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Sep 29, 2026 | 1 month ago |
| RSI: Oversold | Sep 21, 2026 | 1 month ago |
| RSI: Oversold | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| RSI: Oversold | Aug 27, 2026 | 2 months ago |
| RSI: Oversold | Aug 25, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| RSI: Oversold | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Apr 30, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 24, 2026 | 6 months ago |
| SMA: Bearish | Apr 2, 2026 | 7 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| RSI: Overbought | Apr 1, 2026 | 7 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| RSI: Oversold | Dec 11, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 9, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| SMA: Bearish | Nov 12, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| SMA: Bullish | Oct 30, 2025 | 1 year ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 23, 2025 | 1 year ago |
| SMA: Bullish | Oct 14, 2025 | 1 year ago |
| RSI: Overbought | Oct 14, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bullish | Oct 7, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 15, 2025 | 1 year ago |
| RSI: Oversold | Sep 4, 2025 | 1 year ago |
| RSI: Oversold | Sep 2, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 29, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 19, 2025 | 1 year ago |
| SMA: Bearish | Jul 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jul 3, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| RSI: Oversold | Apr 24, 2025 | 1 year ago |
| RSI: Oversold | Apr 15, 2025 | 1 year ago |
| RSI: Oversold | Apr 10, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 19, 2025 | 1 year ago |
| RSI: Oversold | Mar 6, 2025 | 1 year ago |
| RSI: Oversold | Feb 27, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 25, 2025 | 1 year ago |
| RSI: Oversold | Feb 25, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 30, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 24, 2025 | 1 year ago |
| RSI: Oversold | Jan 8, 2025 | 1 year ago |
| RSI: Oversold | Dec 31, 2024 | 1 year ago |
| RSI: Oversold | Dec 24, 2024 | 1 year ago |
Key statistics
- Market cap
- 8.02M
- Enterprise value
- 569.06K
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 3.24
- Price / book
- 11.81
- EPS (TTM)
- -88.92
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -192.08%
- Revenue (TTM)
- 2.47M
- Revenue growth
- 91.30%
- Free cash flow
- -3.57M
- Total cash
- 100.03K
- Total debt
- 140.06K
- Return on equity
- -351.00%
- Shares outstanding
- 3.07M
- Short % of float
- 22.28%
- 50-day average
- 7.79
- 200-day average
- 77.01
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
ELAB Revenue — quarterly 1.31M
ELAB Net income — quarterly -2.94M
ELAB EPS — quarterly -6.06
About PMGC Holdings Inc.
Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- elevaiskincare.com
News
- PMGC Holdings Registers A Doing-Business-As Name As Northstrive Holdings, And Enters Into A Trademark License Agreement With NorthStrive Companies
- PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update
- PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy
- PMGC Holdings’ Northstrive Biosciences Executes Statement Of Work With Charles River To Conduct Analytical Characterization Supporting Development Of EL-22 And EL-32 Engineered Probiotic Programs
- NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
- PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings
- PMGC Holdings’ Northstrive Amends Development And License Agreement With Yuva Biosciences To Launch Three-Phase Program Advancing Four AI-Discovered Compounds And Updating AI Scope, IP, Field Of Use, And Financial Terms
- NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
- 12 Consumer Staples Stocks Moving In Thursday's After-Market Session
- PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio
Your note
Sign in to keep a note on ELAB — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sabby Management, LLC | 0.00% | 12,709 | 33.17K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.00% | 226 | 589 | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.00% | 216 | 563 | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.00% | 196 | 511 | Sep 29, 2024 |
| HRT Financial LP | 0.00% | 179 | 467 | Sep 29, 2024 |
| Diversify Advisory Services, LLC | 0.00% | 125 | 326 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.00% | 226 | 589 | Oct 30, 2024 |